Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and ...

Among patients with moderate to severe atopic dermatitis, atopic comorbidities did not change the benefits seen with lebrikizumab, according to data published in Annals of Allergy, Asthma & Immunology ...

If you’re a person of color, finding the right treatment for atopic dermatitis, a common form of eczema, can be challenging. Even though the disease is more prevalent in Black Americans than white ...

How do early-life exposures shape the infant skin microbiome and atopic dermatitis risk? New cohort data reveal key ...

Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of immunomodulatory activity First-in-class, oral PKM2 modulator, SYX-5219, has the ...

The global atopic dermatitis market size was valued at USD 6.62 billion in 2025 and is predicted to hit around USD 12.97 billion by 2034, rising at a 7.75% CAGR, a study published by Towards ...

Please provide your email address to receive an email when new articles are posted on . Samples of skin microbiota in infants showed lower levels of natural moisturizing in patients who later ...

The ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic dermatitis. All primary and secondary ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...

But when you add being Black to the equation — and the racism and other forms of bias that come with it — those negative feelings can intensify. It’s common for Black people with atopic dermatitis to ...